WSA
XENT

Wall Street Associates’s Intersect ENT, Inc XENT Stock Holding History

Wall Street Associates’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,500
Closed -$214K – 217
2016
Q3 		$214K Hold
13,500
– – 0.07% 214
2016
Q2 		$175K Sell
13,500
-3,100
-19% -$48.5K 0.07% 212
2016
Q1 		$315K Hold
16,600
– – 0.13% 174
2015
Q4 		$373K Hold
16,600
– – 0.1% 244
2015
Q3 		$388K Sell
16,600
-174,400
-91% -$4.81M 0.07% 244
2015
Q2 		$5.47M Buy
191,000
+1,100
+0.6% +$28.8K 0.52% 67
2015
Q1 		$4.91M Sell
189,900
-7,200
-4% -$165K 0.46% 79
2014
Q4 		$3.66M Hold
197,100
– – 0.35% 96
2014
Q3 		$3.06M Buy
+197,100
New +$2.97M 0.32% 106

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wall Street Associates's XENT Position: Q4 2016 in Review

Wall Street Associates sold out of Intersect ENT, Inc (XENT) in Q4 2016, closing a stake of 13,500 shares — an estimated $214K sold.

Wall Street Associates first reported a position in XENT in Q3 2014 and held it in 9 quarters. The position peaked at $5.47M in Q2 2015. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

  • Wall Street Associates reported no remaining Intersect ENT, Inc position as of Q4 2016 after selling out during the quarter.
  • Wall Street Associates sold 13,500 Intersect ENT, Inc shares in Q4 2016, an estimated $214K.
  • Wall Street Associates first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 9 quarters.
  • Wall Street Associates's Intersect ENT, Inc position peaked at $5.47M in Q2 2015.
  • 104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.